菲布羅動物保健公司
US ˙ NasdaqGM ˙ US71742Q1067

SecurityPAHC / Phibro Animal Health Corporation
InstitutionPrudential Financial Inc
Latest Disclosed Ownership45,285 shares
Latest Disclosed Value $ 2,504,713
Prudential Financial Inc reports 29.26% decrease in ownership of PAHC / Phibro Animal Health Corporation

On May 13, 2026 - Prudential Financial Inc filed a 13F-HR form disclosing ownership of 45,285 shares of Phibro Animal Health Corporation (US:PAHC) valued at $2,504,713 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 64,015 shares of Phibro Animal Health Corporation. This represents a change in shares of -29.26% during the quarter. The current value of the position is $1,468,593 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 45,285 -18,730 -29.26 2,505 4.73 0.0017
2026-02-13 2025-12-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 64,015 -77,330 -54.71 2,392 -58.18 0.0029
2025-11-13 2025-09-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 141,345 -4,200 -2.89 5,719 53.83 0.0068
2025-08-12 2025-06-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 145,545 31,902 28.07 3,717 53.15 0.0048
2025-05-13 2025-03-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 113,643 -7,012 -5.81 2,427 -4.18 0.0035
2025-02-11 2024-12-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 120,655 96,800 405.78 2,534 371.69 0.0035
2024-11-14 2024-09-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 23,855 1,100 4.83 537 40.94 0.0008
2024-08-13 2024-06-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 22,755 -1,150 -4.81 382 23.30 0.0006
2024-05-14 2024-03-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 23,905 0 0.00 309 11.96 0.0004
2024-02-13 2023-12-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 23,905 -15 -0.06 277 -9.51 0.0004
2023-11-13 2023-09-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 23,920 -1,270 -5.04 305 -11.59 0.0005
2023-08-11 2023-06-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 25,190 1,800 7.70 345 -3.63 0.0005
2023-05-12 2023-03-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 23,390 -84,715 -78.36 358 -75.29 0.0006
2023-02-14 2022-12-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 108,105 87,300 419.61 1,450 350.00 0.0024
2022-11-04 2022-09-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 20,805 -365 -1.72 322 -20.88 0.0005
2022-08-15 2022-06-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 21,170 -757 -3.45 407 -6.86 0.0006
2022-05-13 2022-03-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 21,927 -8,882 -28.83 437 -35.07 0.0006
2022-02-14 2021-12-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 30,809 -902 -2.84 673 -2.04 0.0008
2021-11-15 2021-09-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 31,711 8,000 33.74 687 0.29 0.0010
2021-08-16 2021-06-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 23,711 -947 -3.84 685 13.79 0.0009
2021-05-12 2021-03-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 24,658 419 1.73 602 27.81 0.0009
2021-08-16 2020-12-31 13F/A-1 PHIBRO ANIMAL HEALTH CL A COM 0019 71742Q106 24,239 23,531 3,323.59 471 3,825.00 0.0008
2021-02-16 2020-12-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 24,239 23,531 471 0.0008
2021-08-05 2020-09-30 13F/A-1 PHIBRO ANIMAL HEALTH CL A COM 71742Q106 708 -137 -16.21 12 -45.45 0.0017
2020-11-16 2020-09-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 28,592 27,747 498 0.0009
2021-08-05 2020-06-30 13F/A-1 PHIBRO ANIMAL HEALTH CL A COM 0026 71742Q106 845 276 48.51 22 57.14 0.0041
2020-08-12 2020-06-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 27,536 26,967 723 0.0014
2021-08-05 2020-03-31 13F/A-1 PHIBRO ANIMAL HEALTH CL A COM 0024 71742Q106 569 49 9.42 14 7.69 0.0036
2020-05-12 2020-03-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 32,204 31,684 778 0.0017
2021-08-05 2019-12-31 13F/A-1 PHIBRO ANIMAL HEALTH CL A COM 0024 71742Q106 520 38 7.88 13 30.00 0.0034
2020-02-11 2019-12-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 32,654 32,172 811 0.0012
2021-08-05 2019-09-30 13F/A-1 PHIBRO ANIMAL HEALTH CL A COM 0021 71742Q106 482 -12 -2.43 10 -37.50 0.0033
2019-11-13 2019-09-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 32,494 32,000 693 0.0011
2021-08-05 2019-06-30 13F/A-1 PHIBRO ANIMAL HEALTH CL A COM 71742Q106 494 -102,076 -99.52 16 -99.53 0.0056
2019-08-08 2019-06-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 33,264 -69,306 1,057 0.0016
2019-05-15 2019-03-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 102,570 -106,257 -50.88 3,385 -49.59 0.0056
2019-02-07 2018-12-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 208,827 -21,746 -9.43 6,715 -32.12 0.0118
2018-11-07 2018-09-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 230,573 -9,095 -3.79 9,892 -10.37 0.0146
2018-08-13 2018-06-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 239,668 50,598 26.76 11,037 47.04 0.0165
2018-05-04 2018-03-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 189,070 51,800 37.74 7,506 63.24 0.0114
2018-02-13 2017-12-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 137,270 -4,490 -3.17 4,598 -12.47 0.0063
2017-11-02 2017-09-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 141,760 52,590 58.98 5,253 58.99 0.0087
2017-08-07 2017-06-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 89,170 41,530 87.17 3,304 146.75 0.0049
2017-05-10 2017-03-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 47,640 -40 -0.08 1,339 -4.15 0.0021
2017-02-07 2016-12-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 47,680 -38,680 -44.79 1,397 -40.48 0.0022
2016-11-04 2016-09-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 86,360 -50,940 -37.10 2,347 -8.39 0.0039
2016-08-09 2016-06-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 137,300 81,100 144.31 2,562 68.55 0.0043
2016-05-09 2016-03-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 56,200 4,600 8.91 1,520 -2.25 0.0027
2016-02-12 2015-12-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 51,600 8,800 20.56 1,555 14.84 0.0028
2015-11-10 2015-09-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 42,800 -46,800 -52.23 1,354 -61.19 0.0027
2015-08-06 2015-06-30 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 89,600 -18,100 -16.81 3,489 -8.52 0.0062
2015-05-01 2015-03-31 13F PHIBRO ANIMAL HEALTH CL A COM 71742Q106 107,700 107,700 3,814 0.0066
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.